TCN1 Deficiency Inhibits the Malignancy of Colorectal Cancer Cells by Regulating the ITGB4 Pathway

키워드

참고문헌 (60)

1. Siegel RL, "Cancer statistics, 2018", CA Cancer J Clin, 68, pp.7~30 (2018)
2. Kawaguchi N, "Nogo-B(Reticulon-4B)functions as a negative regulator of the apoptotic pathway through the interaction with c-FLIP in colorectal cancer cells", Biochim Biophys Acta Mol Basis Dis, 1864, pp.2600~2609 (2018)
3. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185countries", CA Cancer J Clin, 68, pp.394~424 (2018)
4. Chen W, "Cancer statistics in China, 2015", CA Cancer J Clin, 66, pp.115~132 (2016)
5. Lee TY, "Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative", Oncotarget, 7, pp.23512~23520 (2016)
6. Deng WW, "KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells", Mol Cell Biochem, 449, pp.81~90 (2018)
7. Wang Y, "Transcobalamin I : a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers", Onco Targets Ther, 11, pp.4253~4261 (2018)
8. Chong LY, "Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors : novel markers in biological classification", Breast Cancer Res Treat, 132, pp.143~151 (2012)
9. Allen LH, "Biomarkers of Nutrition for Development(BOND) : vitamin B-12 review", J Nutr, 148(suppl_4), pp.1995S~2027S (2018)
10. Waibel R, "New derivatives of vitamin B12 show preferential targeting of tumors", Cancer Res, 68, pp.2904~2911 (2008)
11. Lyon P, "B vitamins and onecarbon metabolism : implications in human health and disease", Nutrients, 12, pp.2867~ (2020)
12. Martinelli M, "A candidate gene study of one-carbon metabolism pathway genes and colorectal cancer risk", Br J Nutr, 109, pp.984~989 (2013)
13. Lederer AK, "Vitamin B12status upon short-term intervention with a vegan diet : a randomized controlled trial in healthy participants", Nutrients, 11, pp.2815~ (2019)
14. Chu CM, "Gene expression profiling of colorectal tumors and normal mucosa by microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees", Dis Markers, 2014, pp.634123~ (2014)
15. Li M, "Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients", Cancer Med, 7, pp.4650~4664 (2018)
16. Zhu X, "Clinicopathological analysis and prognostic assessment of transcobalamin I(TCN1)in patients with colorectal tumors", Med Sci Monit, 26, pp.e923828~ (2020)
17. Liu GJ, "High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer", Sci Rep, 10, pp.11951~ (2020)
18. Giancotti FG, "Targeting integrin beta4 for cancer and antiangiogenic therapy", Trends Pharmacol Sci, 28, pp.506~511 (2007)
19. Wang L, "Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk", Cell Death Dis, 6, pp.e1796~ (2015)
20. Xiao T, "Structural basis for allostery in integrins and binding to fibrinogenmimetic therapeutics", Nature, 432, pp.59~67 (2004)
21. Nagata M, "ITGA3 and ITGB4expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma", BMC Cancer, 13, pp.410~ (2013)
22. Wang H, "Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells", Int J Cancer, 133, pp.416~426 (2013)
23. Zhang W, "Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer", Oncotarget, 8, pp.92333~92345 (2017)
24. Zhong F, "The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma", Pathol Res Pract, 216, pp.152785~ (2020)
25. Blackhall FH, "Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma : results from the European Thoracic Oncology Platform Lungscape Project", J Clin Oncol, 32, pp.2780~2787 (2014)
26. Colla S, "The new tumorsuppressor gene inhibitor of growth family member 4(ING4)regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha(HIF-1alpha)activity : involvement in myeloma-induced angiogenesis", Blood, 110, pp.4464~4475 (2007)
27. Yang N, "Poly(ADP-ribose)polymerase-1 binds to BCL2 major breakpoint region and regulates BCL2 expression", J Cell Biochem, 110, pp.1208~1218 (2010)
28. Wu D, "Pairing of integrins with ECM proteins determines migrasome formation", Cell Res, 27, pp.1397~1400 (2017)
29. Litjens SH, "Specificity of binding of the plectin actin-binding domain to beta4 integrin", Mol Biol Cell, 14, pp.4039~4050 (2003)
30. Pospich S, "Structural effects and functional implications of phalloidin and jasplakinolide binding to actin filaments", Structure, 28, pp.437~449 (2020)
31. Hong D, "Deletion of TMEM268 inhibits growth of gastric cancer cells by downregulating the ITGB4signaling pathway", Cell Death Differ, 26, pp.1453~1466 (2019)
32. Wang W, "Hemidesmosomes modulate force generation via focal adhesions", J Cell Biol, 219, pp.e201904137~ (2020)
33. Weinberg BA, "The growing challenge of young adults with colorectal cancer", Oncology(Williston Park), 31, pp.381~389 (2017)
34. O'Keefe SJ, "Diet, microorganisms and their metabolites, and colon cancer", Nat Rev Gastroenterol Hepatol, 13, pp.691~706 (2016)
35. Durinikova E, "Preclinical models as patients' avatars for precision medicine in colorectal cancer : past and future challenges", J Exp Clin Cancer Res, 40, pp.185~ (2021)
36. Heinemann V, "FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as firstline treatment for patients with metastatic colorectal cancer(FIRE-3) : a randomised, open-label, phase 3 trial", Lancet Oncol, 15, pp.1065~1075 (2014)
37. Boyle T, "Lifestyle factors associated with survival after colorectal cancer diagnosis", Br J Cancer, 109, pp.814~822 (2013)
38. Abdulrahman SS, "Immunohistochemical evaluation of salivary gland tumors differentiation and proliferation by using calponin and telomerase", Saudi Dent J, 31, pp.105~114 (2019)
39. Zhuang H, "Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer", J Cell Mol Med, 24, pp.13481~13493 (2020)
40. Woo JA, "Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers", Cell Death Differ, 22, pp.921~934 (2015)
41. Padilla-Rodriguez M, "The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion", Nat Commun, 9, pp.2980~ (2018)
42. Bianconi D, "Integrins in the spotlight of cancer", Int J Mol Sci, 17, pp.2037~ (2016)
43. Mark H. Ginsberg, "Integrin activation", BMB Reports, 47(12), pp.655~659 (2014), 생화학분자생물학회
44. Li J, "Integrin β4 promotes invasion and anoikis resistance of papillary thyroid carcinoma and is consistently overexpressed in lymphovascular tumor thrombus", J Cancer, 10, pp.6635~6648 (2019)
45. Kadeer A, "Plectin is a novel regulator for apical extrusion of RasV12-transformed cells", Sci Rep, 7, pp.44328~ (2017)
46. Bouameur JE, "Interaction of plectin with keratins 5 and 14 : dependence on several plectin domains and keratin quaternary structure", J Invest Dermatol, 134, pp.2776~2783 (2014)
47. Ganguly KK, "Integrins and metastasis", Cell Adh Migr, 7, pp.251~261 (2013)
48. Yoshioka T, "β4 Integrin signaling induces expansion of prostate tumor progenitors", J Clin Invest, 123, pp.682~699 (2013)
49. Kröger C, "Acquisition of a hybrid E", M state is essential for tumorigenicity of basal breast cancer cells, 2019, pp.116, 7353~7362
50. Masugi Y, "Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma", Lab Invest, 95, pp.308~319 (2015)
51. Yao B, "MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt", β-catenin signaling through targeting BCL9, 2019, pp.47, 3885~3895
52. Scheau C, "The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma", Anal Cell Pathol(Amst), 2019, pp.9423907~ (2019)
53. Gan L, "Extracellular matrix protein 1promotes cell metastasis and glucose metabolism by inducing integrin β4", FAK, HIF-1α signaling pathway in gastric cancer, pp.Oncogene, 2018[DOI]
54. Kurenova E, "The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth", Oncotarget, 4, pp.1632~1646 (2013)
55. Ning Z, "USP22 promotes epithelialmesenchymal transition via the FAK pathway in pancreatic cancer cells", Oncol Rep, 32, pp.1451~1458 (2014)
56. Wu A, "Integrated analysis of prognostic and immune associated integrin family in ovarian cancer", Front Genet, 11, pp.705~ (2020)
57. Li J, "ZKSCAN3 drives tumor metastasis via integrin β4", FAK, Cancer Cell Int, pp.2020, 20[DOI]
58. Tai YL, "Activation of focal adhesion kinase through an interaction with β4 integrin contributes to tumorigenicity of colon cancer", FEBS Lett, 590, pp.1826~1837 (2016)
59. Jang B, "Syndecan-2cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK", ERK signaling pathway in colon cancer, 2017, pp.292, 16321~16332
60. Yang ZY, "Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4", Carcinogenesis, 34, pp.2851~2860 (2013)

관련 논문AI추천